| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/11/2007 | CN1325479C Pyrimidine compounds |
| 07/11/2007 | CN1325462C Novel substituted arylhexadienoic acids and esters thereof which can be used for the treatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositions comprising the |
| 07/11/2007 | CN1325101C Capsule for radix astragalis and red-rooted salvia root |
| 07/11/2007 | CN1325089C Chinese patent medicine on health food composition and its use |
| 07/11/2007 | CN1325072C Method for controling quality of Yixinshu grain |
| 07/11/2007 | CN1325066C Pharmaceutical composition for preventing and treating cerebral ischemic reperfusion injury |
| 07/11/2007 | CN1325063C L-amino acid water-soluble pearl powder and its preparing method |
| 07/11/2007 | CN1325054C Cyclic dextrin inclusion compound of mintpress hydrochloride and its preparing method |
| 07/11/2007 | CN1325052C Benzothiazole derivatives |
| 07/11/2007 | CN1325051C Compound medicine of ozagrel and its salt and troxerutin |
| 07/11/2007 | CN1325044C Drop pills for treating apoplexy diseases and preparation method thereof |
| 07/11/2007 | CN1325041C Freeze dried powder injection for treating thromboangitis obliterans and its preparing process |
| 07/10/2007 | USRE39723 Semi-synthetic taxanes with antitumor and antiangiogenetic activities |
| 07/10/2007 | US7241923 Phenylalkyloxy-phenyl derivatives |
| 07/10/2007 | US7241890 Heat shock protein 90 inhibitors; breast cancer, melanomas; inflammation, infectious diseases, autoimmune disorders, ischemia |
| 07/10/2007 | US7241882 Polyamide nucleic acid derivatives, and agents, and processes for preparing them |
| 07/10/2007 | US7241869 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 07/10/2007 | US7241861 High density lipoprotein-reactive peptides |
| 07/10/2007 | US7241793 For therapy of cardiovascular diseases |
| 07/10/2007 | US7241789 Substituted indoles and their use as integrin antagonists |
| 07/10/2007 | US7241782 Modifications are prepared by subjecting an alkaline solution of torasemide to a rapid acidification with inorganic or organic acids at 0 to 35 degrees C. |
| 07/10/2007 | US7241781 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 07/10/2007 | US7241778 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety |
| 07/10/2007 | US7241777 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors |
| 07/10/2007 | US7241766 Methods of using phenolic guanidine sodium channel blockers |
| 07/10/2007 | US7241765 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 07/10/2007 | US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/10/2007 | US7241738 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/10/2007 | US7241737 Urotensin-II agonists and antagonists |
| 07/10/2007 | US7241733 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 07/10/2007 | US7241619 Identification of genes encoding enzymes (Thraustochytrium aureum Delta 5-desaturase, Saprolegnia diclina Delta 5-desaturase, Saprolegnia diclina Delta 6-desaturase)involved in synthesis of polyunsaturated fatty acids |
| 07/10/2007 | US7241591 Adenovirus comprising a gene coding for glutathione peroxidase |
| 07/10/2007 | US7241576 Applications of a novel cytokine, named THANK, for TNF homologue that activates apoptosis, NF- kappa B and c-jun N-terminal kinase. Such applications include using THANK inhibitors to inhibit the activation of NF-kappa B and to |
| 07/10/2007 | US7241571 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis |
| 07/10/2007 | CA2421910C Xanthine phosphodiesterase v inhibitors |
| 07/10/2007 | CA2396814C Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical compositions containing them |
| 07/10/2007 | CA2199401C Pyrimido[5,4-d]pyrimidines, medicaments comprising these compounds, their use and processes for their preparation |
| 07/10/2007 | CA2190807C Acetylsalicylic acid and tocopherol stable pharmaceutical composition |
| 07/10/2007 | CA2173316C Local polymeric gel cellular therapy |
| 07/10/2007 | CA2128706C Polyunsaturated fatty acid based drugs, in particular docosahexaenoic acid, as platelet aggregation inhibitors and against essential fatty acid deficiencies of the brain |
| 07/10/2007 | CA2124769C Recombinant foamy virus vectors for medicinal and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 07/10/2007 | CA2098849C Control of gene expression by ionizing radiation |
| 07/09/2007 | CA2635370A1 Modulators of hypoxia inducible factor-1 and related uses |
| 07/05/2007 | WO2007076387A1 Phytosterols for use in reducing c-reactive protein levels |
| 07/05/2007 | WO2007076379A2 4,7-dihydrothieno[2,3-b]pyridine compounds and pharmaceutical compositions |
| 07/05/2007 | WO2007076053A2 Stable s-nitrosothiol formulations |
| 07/05/2007 | WO2007075841A1 Omega 3 fatty acid formulations |
| 07/05/2007 | WO2007075151A1 Composite vasodilator based on a no-group donator and a promoter |
| 07/05/2007 | WO2007075009A1 Complex formulation comprising amlodipine camsylate and simvastatin and method for preparation thereof |
| 07/05/2007 | WO2007074995A1 Process for the preparation of s-(+)-clopidogrel by optical resolution |
| 07/05/2007 | WO2007074916A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 07/05/2007 | WO2007074859A1 Anti-c-mannosylated peptide antibody and use thereof |
| 07/05/2007 | WO2007074753A1 Pharmaceutical comprising substituted urea derivative |
| 07/05/2007 | WO2007073934A1 Pyridinyl amine derivatives as inhibitors of cholesteryl ester transfer protein (cetp) |
| 07/05/2007 | WO2007073682A1 Dropping pill of butylbenzene phthalein and its application |
| 07/05/2007 | WO2007047880A3 Compositions for lowering serum cholesterol and/or triglycerides |
| 07/05/2007 | WO2007017894B1 PREPARATION OF NOVEL CRYSTALLINE η(ETA) FORM OF PERINDOPRIL ERBUMINE |
| 07/05/2007 | US20070157326 Ee3-protein family and corresponding dna sequence |
| 07/05/2007 | US20070156232 Medical Device with Coating that Promotes Endothelial Cell Adherence |
| 07/05/2007 | US20070155970 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives |
| 07/05/2007 | US20070155808 G Protein-Coupled Receptors (GPR40); insulin secretagogue; diabetes; 3-[4-[[4-[[(2-Phenylethyl)(4-phenyl-1,3-thiazol-2-yl)amino]methyl]benzyl]oxy]phenyl]propanoic acid |
| 07/05/2007 | US20070155804 Mitotic kinesin inhibitor |
| 07/05/2007 | US20070155788 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155775 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155762 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an anticholesterol agent; inhibitor of platlet activating factor acetylhydrolase |
| 07/05/2007 | US20070155756 Treatment of chemokine mediated diseases |
| 07/05/2007 | US20070155745 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
| 07/05/2007 | US20070155740 1-(1H-Pyrazin-2-on-3-yl)-tetrahydroquinolines or tetrahydro-1,4-benzoxazines (3-(8-Bromo-6-methoxy-1,2,3,4-tetrahydroquinoline)-5-chloro-1-(1-ethylpropyl)-2(1H)-pyrazinone); affective disorder, anxiety and depression |
| 07/05/2007 | US20070155734 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/05/2007 | US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents |
| 07/05/2007 | US20070155728 Substituted Heterocyclic Compounds |
| 07/05/2007 | US20070155724 Methods of Treating Cytokine Mediated Diseases |
| 07/05/2007 | US20070155719 Platelet ADP receptor inhibitors |
| 07/05/2007 | US20070155713 Nitrogen-containing heterocyclic compounds and use thereof |
| 07/05/2007 | US20070155703 Pharmaceutically active compounds and methods of use thereof |
| 07/05/2007 | US20070155679 Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations |
| 07/05/2007 | US20070155678 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 07/05/2007 | US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction |
| 07/05/2007 | US20070155670 Pyrrolidine Melanocortin-Specific Compounds |
| 07/05/2007 | US20070155657 Hypoglycemic agent |
| 07/05/2007 | US20070155656 Hypoglycemic agent |
| 07/05/2007 | US20070155655 Zinc (vitamin C)2 complex; low toxicity; insulin mimetics; stability; fat soluble; diabetes |
| 07/05/2007 | US20070154918 44 Human Secreted Proteins |
| 07/05/2007 | US20070154912 87 Human Secreted Proteins |
| 07/05/2007 | US20070154569 Use of nitrite salts for the treatment of cardiovascular conditions |
| 07/05/2007 | US20070154392 treating a cancerous disease which includes characterizing a disease by an overexpression of one or more somatostatin receptors, exposing such somatostatin receptors to a pharmaceutical formulation containing a somatostatin analogue which binds to the one or more somatostatin receptor |
| 07/05/2007 | DE20122736U1 Beschichteter Ballonkatheter Coated balloon catheter |
| 07/05/2007 | DE102005061171A1 Neue, cyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung New, cyclic, substituted Furopyrimidin derivatives and their use |
| 07/05/2007 | DE102005061170A1 Neue, acyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung New acyclic Furopyrimidin substituted derivatives and their use |
| 07/05/2007 | CA2821393A1 Rnai-mediated inhibition of rho kinase for treatment of ocular hypertension/glaucoma |
| 07/05/2007 | CA2635255A1 Process for the preparation of s-(+)-clopidogrel by optical resolution |
| 07/05/2007 | CA2634833A1 Pyridinyl amine derivatives as inhibitors of cholesteryl ester transfer protein (cetp) |
| 07/05/2007 | CA2634639A1 Complex formulation comprising amlodipine camsylate and simvastatin and method for preparation thereof |
| 07/05/2007 | CA2634437A1 4,7-dihydrothieno¬2,3-b|pyridine compounds and pharmaceutical compositions |
| 07/05/2007 | CA2634216A1 Thrombin receptor antagonists as prophylaxis to complications from cardiopulmonary surgery |
| 07/05/2007 | CA2634139A1 Omega 3 fatty acid formulations |
| 07/05/2007 | CA2633993A1 Phytosterols for use in reducing c-reactive protein levels |
| 07/05/2007 | CA2633353A1 Stable s-nitrosothiol formulations |
| 07/05/2007 | CA2632508A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 07/05/2007 | CA2611293A1 Process for the preparation of tetrazolyl compounds |